. However, the biochemical parameters of liver injury caused by PFOA during pregnancy have not been reported yet.
The developmental toxicity induced by exposure to PFOA during gestation includes dose-related full litter resorptions, reduced fetal weight, reduced postnatal survival, delays in postnatal growth and development in offspring Lau et al., 2004 Lau et al., , 2006 . A cross-foster study indicates that the postnatal effects on survival, eye opening and weight gain are a consequence of gestational exposure and that exposure via lactation is not a major factor . However, the exact cause of neonatal death has not been explained yet.
Perfuorooctane sulfonate (PFOS), a similar compound to PFOA, also induces developmental and reproductive effects, such as reduced birth weight, decreased gestational length, structural defects, developmental delays, and increased neonatal mortality (Grasty et al., 2003; Lau et al., 2003; Luebker et al., 2005a Luebker et al., , 2005b Thibodeaux et al., 2003) . In our previous study on neonatal death in mice exposed to PFOS, we found that PFOS exposure during pregnancy lead to intracranial blood vessel dilatation accompanied by severe lung collapse which caused neonatal mortality (Yahia et al., 2008) . However, the neonatal death caused by PFOA has not been examined in relation to the intracranial blood vessel dilatation.
The aim of this study is to examine the biochemical, hepatic and developmental effects of PFOA in mice exposed during pregnancy and the cause of neonatal death.
MATERIALS AND METHODS

Animals
Adult ICR male and female mice were purchased from CLEA Japan, Inc., Tokyo, Japan at seven weeks of age and used for the experiment after one week of acclimatization. Animals were housed in aluminum cages with cedar shavings for bedding and provided pellet chow (MF, Oriental Yeast Co., Ltd, Tokyo, Japan) and tap water ad libitum. Animal facilities were controlled for temperature (20-24°C) and operated under a 12 hr light-dark cycle. Animal experiments were conducted according to the Guidelines for Animal Experiments in Iwate University, Morioka, Japan.
Mating
Female mice were checked for estrous cycle stage and each proestrus female was placed with an individually housed male overnight, and those animals with spermatozoa in a vaginal smear and/or with a copulatory plug were considered to be at gestational day (GD) 0. Pregnant dams were housed individually.
Animal treatment and sampling
PFOA (90% pure) was purchased from Fluka Chemie GmbH. PFOA solutions were prepared at 0.1, 0.5 and 1 mg/ml by deionized water and administered to the pregnant mice at 1 5 and 10 mg/kg by gavage at a volume of 10 ml/kg once daily from GD 0 to the end of the study (GD 17 for prenatal study, GD 18 for postnatal study). Controls received an equivalent volume of water.
Maternal body weights as well as food and water consumption were monitored daily throughout gestation. Five to nine dams per group were euthanized on GD 18 (24 hr after the last treatment) under diethyl ether anesthesia for serum biochemical analysis, histopathological examination of maternal liver, kidneys, lungs and brain, and teratological evaluation. The other 10 dams per group were left to give birth.
Serum analysis
Serum samples were used for determination of blood serum levels of lactate dehydrogenase (LDH), gamma glutamyl transfers (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), creatinine, blood urea nitrogen (BUN), total bilirubin, total protein, albumin, globulins, calcium, inorganic phosphorus, glucose, triglycerides, phospholipids, total cholesterol, free fatty acids and hydroxy butyric acid by using an auto analyzer (Accute TBA-40FR, Toshiba Medical Systems Corporation, Tokyo, Japan).
Histopathological examination of maternal organs
Maternal liver, kidney, lung and brain were kept in 10% buffered formalin at room temperature, embedded in paraffin wax, sectioned and stained with hematoxylin and eosin.
Prenatal evaluation
The gravid uterus was removed and examined, and the numbers of the live or dead fetuses as well as resorptions were recorded. Live fetuses were weighed individually and examined for external abnormalities. All fetuses removed from the deeply anesthetized dam were immediately euthanized by 70% ethanol, eviscerated, fixed in 95% ethanol and subsequently stained with alizarin red and alcian blue to visualize bone and cartilage, respectively. Skeletal morphology was evaluated as described by Narotsky and Rogers (2000) .
Postnatal evaluation
We examined neonatal lungs, because Grasty et al. (2003) suggested that the cause of neonatal death in rats exposed to PFOS was lung immaturity. Neonatal head was examined because we found intracranial blood vessel dilatation in mice exposed to PFOS in our previous study related to neonatal death in mice exposed to PFOS (Yahia et al., 2008) . Five dams (out of 10) per group were treated from GD 0 to GD 18 and left to give birth, after delivery the neonates were observed during day time for 4 days to determine the neonatal mortality. The other 5 dams per group were treated from GD 0 to GD 18 and left to give birth, all neonates were collected and kept in Bouin's solution and examined pathologically. Two samples per litter were randomly selected and were routinely embedded in paraffin wax, sectioned at 4 μm in thickness and stained with hematoxylin and eosin.
Statistical analysis
The differences in any parameter of the fetuses, pups or dams between the average of treated dams and the concurrent control dams were compared with Dunnett test after one way ANOVA. A p-value less than 0.05 was considered statistically significant.
RESULTS
Maternal effects
Maternal exposure to PFOA during pregnancy did not cause any apparent toxic signs or mortalities in all the exposed groups. A significant reduction in weight gain was observed at 10 mg/kg group from GD 12 till the end of gestation. There was significant decrease in food intake in that group in early stage of gestation but not in late of gestation. At 5 mg/kg there was a significant increase in feed consumption and water intake late in gestation (data not shown).
Treatment of pregnant mice with PFOA increased the maternal absolute and relative liver weight in a dose dependent manner and reduced the absolute brain weight at the 10 mg/kg group. PFOA increased the relative kidney weight in all treated groups (Table 1) .
Pathological examination of maternal organs showed hepatocellular hypertrophy and increased mitosis in all the treated groups and single cell necrosis and mild calcification at 10 mg/kg group (Fig.1) . Hypertrophied hepatocytes were observed in central lobular area at low and middle doses, and diffusely spread throughout lobules at high dose. The kidney showed slight hypertrophy in the outer medulla and proximal tubular cells in all the treated mice. There were no changes in maternal lung and brain in all the exposed mice.
At 10 mg/kg group, PFOA caused changes in serum biochemical parameters such as increased GGT, AST, ALP and albumin globulin (A/G) ratio, but reduced the total protein, albumin, globulins, triglycerides, phospholipids, total cholesterol and free fatty acids (Table 2) .
Prenatal study
PFOA treatment reduced the fetal body weight at 5 and 10 mg/kg groups. There were no significant effects on the prenatal survival, in addition to absence of gross abnor- Table 1 . Whole body weight and organ weight of dams on GD18 Control (n = 7) 1 mg/kg (n = 9) 5 mg/kg (n = 5) 10 mg/kg (n = 8)
Whole body g 68.3 ± 1.7 63.7 ± 1.3 60.2 ± 1.7* 56.7 ± 2.7** Liver g 2.77 ± 0. Vol. 35 No. 4 malities in all the examined fetuses, while there were few skeletal anomalies as delayed ossification of the sternum and phalanges accompanied by delayed eruption of incisors at 10 mg/kg group. The results of the prenatal study were summarized in Table 3 .
Postnatal study PFOA at 10 mg/kg caused delayed delivery as reported elsewhere (Lau et al., 2006) , all the observed 5 dams delivered in early morning or during the day time, which made us possible to observe the pup's behavior. Surprisingly, about 58% of pups were still born, though about 95% of fetuses had been alive when examined on GD 18 at 10 mg/kg group. The remaining live pups at 10 mg/kg group were active at parturition but all died within 6 hr after birth. At 5 mg/kg group 16% of neonates died during the 4 days observation. Significant reductions in neonatal body weight were detectable in the 5 and 10 mg/ kg groups (Table 4) . After delivery, no abnormal nursing behavior was observed in the dams.
Pathological examination revealed that there were no changes between the control and exposed mice either in the lung or brain except that some neonates at 10 mg/kg group showed whole body edema.
DISCUSSION
Results of the current study for maternal effects such as reduced weight gain and feed intake, and remarkable increase in liver weight are similar to but stronger than those of previous studies in mice (Lau et al., 2006; Wolf et al., 2007) . Since PFOA is an agonist of peroxisome proliferator-activated receptor (PPAR)-alpha, the PFOAinduced liver enlargement is attributed to the effect on PPAR-alpha (Chevalier et al., 2000; Wolf et al., 2008) .
The significant increases in serum AST, GGT and ALP, which reflect mainly the status of the liver (Bogin et al., 1986) , confirmed the gross and histopathological findings recorded in the present study. The increase in hepatic enzymes was consistent with those observed in male mice (Son et al., 2008) . The hypolipidemia that was observed in this study (reduction in serum levels of triglycerides, Abnormal tail (%) 11.3 ± 7.0 2.3 ± 1.5 4.4 ± 1.8 9.6 ± 8.1
Data represent the mean ± S.E. of examined dams. *: p < 0.05. **: p < 0.01. cholesterol, phospholipids and free fatty acids) is similar to the previous studies, where feeding a diet containing 0.02% PFOA for 7 days to male mice caused severe adipose tissue atrophy and hypolipidemia (Xie et al., 2003) . Thus, the pregnant state did not remarkably affect the effect of PFOA on the biochemical parameters. The effects of PPAR-alpha agonist include increased betaoxidation of fatty acids, increase in several cytochrome P450-mediated reactions, and inhibition of the secretion of very low density lipoproteins and cholesterol from the liver Peraza et al., 2006) . Thus, in addition to liver hypertrophy, the changes in biochemical parameters are also attributed to the effect of PFOA on PPAR-alpha. Hypoproteinemia observed at 10 mg/kg might reflect the maternal body weight loss. Maternal exposure to PFOA reduced the neonatal body weight and survival rate at 5 and 10 mg/kg groups. At 10 mg/kg PFOA group, about 95% of fetuses had been alive when examined on GD 18, but about 58% of neonates were still born, and the others died within 6 hr after birth. These results are reminiscent of the findings reported by Wolf et al. (2007) , where exposure to a high dose of PFOA (20 mg/kg) from GD 15 to 17 was sufficient to produce neonatal mortality and birth weight reduction.
Few skeletal anomalies as delayed ossification of the sternum and phalanges accompanied by delayed eruption of incisors were observed in fetuses exposed to PFOA at 10 mg/kg. These changes are similar to those reported by Lau et al. (2006) . However, pathological examination of neonatal lungs and brain revealed that PFOA did not cause any changes from the control, and we couldn't detect the cause of neonatal death.
Although the mechanism is not clear, Abbott et al. (2007) showed PFOA induced developmental toxicity was dependent on expression of PPAR-alpha using PPARalpha knockout mice. Because PFOA crosses the placenta (Apelberg et al., 2007) , effects on the fetal PPAR-alpha might be involved in the fetal or neonatal death of mice.
We (Yahia et al., 2008) found that PFOS exposure to mice during pregnancy led to intracranial blood vessel dilatation of fetuses accompanied by severe lung collapse, which caused sudden neonatal mortality without causing still born. In spite of the fact that PFOS and PFOA are similar in causing neonatal death, the mechanism of the neonatal death may be different.
